IHH Healthcare

SINGAPORE (Nov 27): IHH Healthcare reported 3Q earnings fell more than half to RM82.1 million ($26.9 million) from $173.3 million a year ago on higher costs from depreciation and amortisation and finance costs from the two new hospitals in Hong Kong and I

SINGAPORE (Sept 5): The SGX All Healthcare Index has reported a price gain of 2.7%, outperforming MSCI AC Asia ex Japan Health Care Index’s 1.9%, in terms of SGD.

SINGAPORE (July 31): IHH Healthcare, through its indirect wholly-owned subsidiary Parkway Pantai, has subscribed for a 55% equity interest in Angsana Holding for a total consideration of $9.3 million.

SINGAPORE (July 5): Maybank Kim Eng Research is keeping healthcare services provider IHH Healthcare on “hold” with a marginally lower target price RM6.15 ($1.98), from RM6.17 previously.

SINGAPORE (July 3): The volume of IPO funds raised by end-2017 is expected to surpass 2016 levels with professional services leading the way as the sector with the most funds raised, according to PricewaterhouseCoopers (PwC) Singapore.  

SINGAPORE (June 19): UOB Kay Hian is remaining “market weight” on Singapore’s healthcare sector on expectations of decelerating medical tourism growth in Singapore, due to rising competition from neighbouring Asean countries such as Malaysia. 

SINGAPORE (June 9): IHH Healthcare, together with its strategic partner Taikang Insurance Group and joint venture (JV) partner Shanghai Hongxin Medical Investment Holding, today broke ground for Gleneagles Shanghai Hospital.

SINGAPORE (June 5): Maybank Kim Eng Research is maintaining its “hold” call on IHH Healthcare with a higher price target of RM6.17 ($2) from RM5.62 previously, highlighting the stock as a healthcare leader in the premium hospital segment with a strong

SINGAPORE (May 19): IHH Healthcare reported 1Q earnings doubled to RM470 million ($151.2 million), following a RM313.4 million gain from the group’s divestment of a 6.07% stake in Apollo Hospitals.

(March 27): Fortis Healthcare, India’s second-largest private hospital chain by market value, is weighing a buyout of the Singapore-listed business trust that owns some of its clinics, people with knowledge of the matter said.